FDA advisory panel recommends approval of Celltrion, Teva's biosimilar of Roche's Rituxan https://www.firstwordpharma.com/node/1596463?tsid=28®ion_id=6 …

13:46 EDT 10 Oct 2018 | FirstWord Pharma

FDA advisory panel recommends approval of Celltrion, Teva's biosimilar of Roche's Rituxan https://www.firstwordpharma.com/node/1596463?tsid=28&region_id=6 …

More From BioPortfolio on "FDA advisory panel recommends approval of Celltrion, Teva's biosimilar of Roche's Rituxan https://www.firstwordpharma.com/node/1596463?tsid=28®ion_id=6 …"